---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-290709"
form_type: "8-K"
ticker: "BNTC"
cik: "0001808898"
company_name: "Benitec Biopharma Inc."
filed_at: "2023-12-07T23:59:59+00:00"
generated_at: "2026-06-07T16:21:08.412138+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Benitec Biopharma stockholders approve all four proposals at 2023 Annual Meeting

## Summary
- Stockholders elected Edward Smith as director: 1,324,883 for, 54,894 withhold, 496,015 broker non-votes.
- Ratification of independent auditor approved: 1,782,870 for, 57,064 against, 35,856 abstain.
- Advisory vote on executive compensation approved: 1,327,852 for, 47,430 against, 4,493 abstain.
- Amendment to 2020 Equity and Incentive Compensation Plan approved: 1,320,120 for, 56,877 against, 2,778 abstain.

## SEC filing metadata
- accession: 0001193125-23-290709
- form_type: 8-K
- ticker: BNTC
- cik: 0001808898
- company_name: Benitec Biopharma Inc.
- filed_at: 2023-12-07T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1808898/000119312523290709/0001193125-23-290709-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1808898/000119312523290709/d555443d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-290709
- JSON: https://secwatch.observer/filing/0001193125-23-290709.json
- Plain text: https://secwatch.observer/filing/0001193125-23-290709.txt

## Key facts
- Shareholder Votes
  Benitec Biopharma Inc. shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm at the 2023-12-06 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-12-06
  source text: Proposal 2 – Ratification of Appointment of Independent Registered Public Accounting Firm. The results were as follows: For Against Abstain 1,782,870 57,064 35,856
  evidence_url: https://www.sec.gov/Archives/edgar/data/1808898/000119312523290709/0001193125-23-290709-index.htm
- Shareholder Votes
  Benitec Biopharma Inc. shareholders approved Approval of Amendment to the 2020 Equity and Incentive Compensation Plan at the 2023-12-06 meeting.
  - Proposal: equity plan
  - Outcome: passed
  - Meeting: 2023-12-06
  source text: Proposal 4 – Approval of Amendment to the 2020 Equity and Incentive Compensation Plan. The results were as follows: For Against Abstain Broker Non-Vote 1,320,120 56,877 2,778 496,015
  evidence_url: https://www.sec.gov/Archives/edgar/data/1808898/000119312523290709/0001193125-23-290709-index.htm
- Shareholder Votes
  Benitec Biopharma Inc. shareholders approved Advisory Vote on Executive Compensation at the 2023-12-06 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2023-12-06
  source text: Proposal 3 – Advisory Vote on Executive Compensation. The results were as follows: For Against Abstain Broker Non-Vote 1,327,852 47,430 4,493 496,015
  evidence_url: https://www.sec.gov/Archives/edgar/data/1808898/000119312523290709/0001193125-23-290709-index.htm
- Shareholder Votes
  Benitec Biopharma Inc. shareholders approved Election of Directors at the 2023-12-06 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-12-06
  source text: Proposal 1 – Election of Directors . The results were as follows: Director Nominee For Withhold Broker Non-Votes Edward Smith 1,324,883 54,892 496,015
  evidence_url: https://www.sec.gov/Archives/edgar/data/1808898/000119312523290709/0001193125-23-290709-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.